A monoclonal antibody IMab-1 specifically recognizes IDH1R132H, the most common glioma-derived mutation

Yukinari Kato, Genglin Jin, Chien Tsun Kuan, Roger E. McLendon, Hai Yan, Darell D. Bigner

研究成果: Article査読

90 被引用数 (Scopus)


IDH1 (isocitrate dehydrogenase 1) mutations have been identified as early and frequent genetic alterations in astrocytomas, oligodendrogliomas, and oligoastrocytomas as well as secondary glioblastomas. In contrast, primary glioblastomas very rarely contain IDH1 mutations, although primary and secondary glioblastomas are histologically indistinguishable. The IDH1 mutations are remarkably specific to a single codon in the conserved and functionally important Arg132 in IDH1. In gliomas, the most frequent IDH1 mutations (>90%) were G395A (R132H). In this study, we immunized mice with R132H-containing IDH1 (IDH1R132H) peptide. After cell fusion using Sendai virus envelope, the monoclonal antibodies (mAbs), which specifically reacted with IDH1R132H, were screened in ELISA. One of the mAbs, IMab-1 reacted with the IDH1R132H peptide, but not with wild type IDH1 (IDH1wt) peptide in ELISA. In Western-blot analysis, IMab-1 reacted with only the IDH1R132H protein, not IDH1wt protein or the other IDH1 mutants, indicating that IMab-1 is IDH1R132H-specific. Furthermore, IMab-1 specifically stained the IDH1R132H-expressing cells in astrocytomas in immunohistochemistry, whereas it did not react with IDH1R132H-negative primary glioblastoma sections. In conclusion, we established an anti-IDH1R132H-specific monoclonal antibody IMab-1, which should be significantly useful for diagnosis and biological evaluation of mutation-bearing gliomas.

ジャーナルBiochemical and biophysical research communications
出版ステータスPublished - 2009 12月 18

ASJC Scopus subject areas

  • 生物理学
  • 生化学
  • 分子生物学
  • 細胞生物学


「A monoclonal antibody IMab-1 specifically recognizes IDH1R132H, the most common glioma-derived mutation」の研究トピックを掘り下げます。これらがまとまってユニークなフィンガープリントを構成します。